18.92
Denali Therapeutics Inc Aktie (DNLI) Neueste Nachrichten
Privium Fund Opens $5.07 Million Denali Stake Ahead of FDA Drug Approval - The Motley Fool
MSN Money - MSN
Assessing Denali Therapeutics (DNLI) Valuation After Takeda Ends DNL593 Partnership - Sahm
Why Denali Therapeutics (DNLI) Is Down 8.2% After Takeda Exits DNL593 Collaboration And Returns Rights - Yahoo Finance
DNLI gains 25.4% year to date: Should you buy, sell or hold the stock? - MSN
D.A. Davidson & CO. Invests $1.77 Million in Denali Therapeutics Inc. $DNLI - MarketBeat
Denali: The First Commercial Validation Of The Blood-Brain Barrier Platform - Seeking Alpha
Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive? - Yahoo Finance
Precision Trading with Denali Therapeutics Inc. (DNLI) Risk Zones - Stock Traders Daily
Denali Therapeutics Inc. $DNLI Shares Bought by Pictet Asset Management Holding SA - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.1%What's Next? - MarketBeat
Denali Therapeutics Reclaims DNL593 Rights After Takeda Collaboration Ends - HarianBasis.co
What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in - Yahoo Finance
10 Best Biotech Stocks with Highest Upside Potential - Insider Monkey
Denali gains on FDA approval of lead asset - MSN
DNLI Stock Price, Quote & Chart | DENALI THERAPEUTICS INC (NASDAQ:DNLI) - ChartMill
FDA clears Denali Therapeutics drug as first brain-penetrating biologic for rare disease - MSN
Denali Therapeutics dips after pricing $200M equity offering - MSN
B. Metzler seel. Sohn & Co. AG Makes New $1.84 Million Investment in Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Stock Rating Lowered by Wall Street Zen - MarketBeat
Bernstein Upgrades Takeda Pharmaceutical (TAK) to Outperform - Yahoo Finance Singapore
Leerink Partners Cuts Denali Therapeutics (NASDAQ:DNLI) Price Target to $35.00 - MarketBeat
Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches - BioSpace
Denali Therapeutics (DNLI) CMO restates 204,402-share insider stake in Form 3/A - Stock Titan
Form DEFA14A Denali Therapeutics Inc. - StreetInsider
[ARS] Denali Therapeutics Inc. SEC Filing - Stock Titan
Denali Therapeutics (NASDAQ: DNLI) sets 2026 virtual meeting and pay vote - Stock Titan
Wedbush Cuts Price Target on Denali Therapeutics to $25 From $30, Keeps Outperform Rating - marketscreener.com
Denali Therapeutics (DNLI) CMO details 170,612-share equity stake in Form 3 - Stock Titan
Targeted therapies dominate March’s five NME approvals - BioWorld News
Denali (DNLI) Stock: Why Smart Money Likes It (Investor Interest) 2026-04-20Social Buy Zones - Cổng thông tin điện tử Tỉnh Sơn La
Orsini Selected as the Exclusive Specialty Pharmacy and Home Infusion Partner for Denali Therapeutics' AVLAYAH™ (tividenofusp alfa-eknm) - BioSpace
Technical Reactions to DNLI Trends in Macro Strategies - Stock Traders Daily
DNLI Should I Buy - Intellectia AI
Why Denali Therapeutics (DNLI) Is Up 7.4% After Regaining Full Rights To DNL593 Collaboration - Sahm
DNLI Gains 25.4% Year to Date: Should You Buy, Sell or Hold the Stock? - TradingView
Hunter Syndrome Market to Surpass USD 1.2 Billion by 2036 | 15+ Emerging Therapies and 10+ Companies Driving Innovation, analyses DelveInsight - Barchart
DNLI.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Retail Surge: Can Denali Therapeutics Inc withstand a market correction2026 Drop Watch & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Pullback Watch: Is Denali Therapeutics Inc stock suitable for long term investingQuarterly Trade Report & Smart Money Movement Tracker - baoquankhu1.vn
Denali Therapeutics Inc. $DNLI Shares Acquired by Baillie Gifford & Co. - MarketBeat
Assessing Denali Therapeutics (DNLI) Valuation After Recent Share Pullback And Pipeline Growth Expectations - Sahm
Pullback Watch: Can Denali Therapeutics Inc withstand a market correctionMarket Activity Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
Retail Surge: What are analysts price targets for Denali Therapeutics IncPrice Action & Risk Controlled Swing Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (DNLI) Edition - Stock Traders Daily
Q3 EPS Estimate for Denali Therapeutics Increased by Analyst - MarketBeat
How AVLAYAH’s Accelerated Approval and Takeda Exit Will Impact Denali Therapeutics (DNLI) Investors - Sahm
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):